Categories: HealthcareNews

Notice of AGM

DXS INTERNATIONAL PLC

Notice of 2022 Annual General Meeting

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems confirms that its Annual General Meeting is scheduled to take place on Thursday 1st December 2022 at 11:30am at the Pavilion Café, Tanshire Park, Shackleford Road, Elstead, Surrey GU8 6LB.

For further information in relation to the AGM shareholders should refer to the Notice of Annual General Meeting and the AGM Letter which have been despatched to shareholders. Copies of these documents, along with the Company’s Annual Report for the year ended 30 April 2022, are available for download from the Company’s website www.dxs-system.co.uk.

The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman      (Chief Executive)
DXS International plc
01252 719800
david@dxs-systems.com
Wrecclesham House
Wrecclesham Road
Farnham
Surrey
GU10 4PS
 
www.dxs-systems.co.uk  

Corporate Advisor

 

 
David Papworth
City & Merchant
0207 101 7676

 

Corporate Broker

 

 
Hybridan LLP
Claire Louise Noyce

 

020 3764 2341

 

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

 

Staff

Recent Posts

Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

1 hour ago

Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 10, 2024 / Biophytis SA (Euronext…

2 hours ago

Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges

BEIJING--(BUSINESS WIRE)--Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered…

8 hours ago

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

SOUTH SAN FRANCISCO, Calif., June 08, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO),…

2 days ago